{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:16:19Z","timestamp":1769609779596,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["504079349"],"award-info":[{"award-number":["504079349"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["263024513"],"award-info":[{"award-number":["263024513"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["504079349"],"award-info":[{"award-number":["504079349"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aufzien Family Center for the Prevention and Treatment of Parkinson\u2019s Disease , Nasjonalforeningen","award":["16154"],"award-info":[{"award-number":["16154"]}]},{"name":"HelseS\u00d8","award":["2019054"],"award-info":[{"award-number":["2019054"]}]},{"DOI":"10.13039\/501100016242","name":"Barnekreftforeningen","doi-asserted-by":"publisher","award":["19008"],"award-info":[{"award-number":["19008"]}],"id":[{"id":"10.13039\/501100016242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013609","name":"EEA Grants\/Norway Grants","doi-asserted-by":"publisher","award":["TO01000078"],"award-info":[{"award-number":["TO01000078"]}],"id":[{"id":"10.13039\/501100013609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["327571"],"award-info":[{"award-number":["327571"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008131","name":"Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008131","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The discovery of both distinctive lead molecules and novel drug targets is a great challenge in drug discovery, which particularly accounts for orphan diseases. Huntington\u2019s disease (HD) is an orphan, neurodegenerative disease of which the pathology is well-described. However, its pathophysiological background and molecular mechanisms are poorly understood. To date, only 2 drugs have been approved on the US and European markets, both of which address symptomatic aspects of this disease only. Although several hundreds of agents were described with efficacy against the HD phenotype in in vitro and\/or in vivo models, a successful translation into clinical use is rarely achieved. Two major impediments are, first, the lack of awareness and understanding of the interactome\u2014the sum of key proteins, cascades, and mediators\u2014that contributes to HD initiation and progression; and second, the translation of the little gained knowledge into useful model systems. To counteract this lack of data awareness, we manually compiled and curated the entire modulator landscape of successfully evaluated pre-clinical small-molecule HD-targeting agents which are annotated with substructural molecular patterns, physicochemical properties, as well as drug targets, and which were linked to benchmark databases such as PubChem, ChEMBL, or UniProt. Particularly, the annotation with substructural molecular patterns expressed as binary code allowed for the generation of target-specific and -unspecific fingerprints which could be used to determine the (poly)pharmacological profile of molecular-structurally distinct molecules.<\/jats:p>","DOI":"10.1186\/s13321-023-00775-z","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T11:02:02Z","timestamp":1700218922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["HD_BPMDS: a curated binary pattern multitarget dataset of Huntington\u2019s disease\u2013targeting agents"],"prefix":"10.1186","volume":"15","author":[{"given":"Sven Marcel","family":"Stefan","sequence":"first","affiliation":[]},{"given":"Jens","family":"Pahnke","sequence":"additional","affiliation":[]},{"given":"Vigneshwaran","family":"Namasivayam","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"issue":"1","key":"775_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13321-022-00620-9","volume":"14","author":"HO Brinkhaus","year":"2022","unstructured":"Brinkhaus HO, Zielesny A, Steinbeck C, Rajan K (2022) DECIMER-hand-drawn molecule images dataset. J Cheminform 14(1):36. https:\/\/doi.org\/10.1186\/s13321-022-00620-9","journal-title":"J Cheminform"},{"issue":"1","key":"775_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13321-020-00465-0","volume":"12","author":"K Rajan","year":"2020","unstructured":"Rajan K, Brinkhaus HO, Zielesny A, Steinbeck C (2020) A review of optical chemical structure recognition tools. J Cheminform 12(1):60. https:\/\/doi.org\/10.1186\/s13321-020-00465-0","journal-title":"J Cheminform"},{"issue":"4","key":"775_CR3","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1021\/jm5002056","volume":"57","author":"MK Gilson","year":"2014","unstructured":"Gilson MK, Georg G, Wang S (2014) Digital chemistry in the Journal of Medicinal Chemistry. J Med Chem 57(4):1137. https:\/\/doi.org\/10.1021\/jm5002056","journal-title":"J Med Chem"},{"issue":"8","key":"775_CR4","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1021\/jm300429z","volume":"55","author":"J Bajorath","year":"2012","unstructured":"Bajorath J (2012) Progress in computational medicinal chemistry. J Med Chem 55(8):3593\u20133594. https:\/\/doi.org\/10.1021\/jm300429z","journal-title":"J Med Chem"},{"key":"775_CR5","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.387984","author":"SM Stefan","year":"2023","unstructured":"Stefan SM, Rafehi M (2023) The big data challenge \u2013 and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond. Neural Regen Res. https:\/\/doi.org\/10.4103\/1673-5374.387984","journal-title":"Neural Regen Res"},{"issue":"1","key":"775_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41597-022-01506-z","volume":"9","author":"SM Stefan","year":"2022","unstructured":"Stefan SM, Jansson PJ, Pahnke J, Namasivayam V (2022) A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors. Sci Data 9(1):446. https:\/\/doi.org\/10.1038\/s41597-022-01506-z","journal-title":"Sci Data"},{"issue":"6","key":"775_CR7","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1021\/acs.jmedchem.0c02199","volume":"64","author":"V Namasivayam","year":"2021","unstructured":"Namasivayam V, Silbermann K, Wiese M, Pahnke J, Stefan SM (2021) C@PA: computer-aided pattern analysis to predict multitarget ABC transporter inhibitors. J Med Chem 64(6):3350\u20133366. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c02199","journal-title":"J Med Chem"},{"key":"775_CR8","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1016\/j.csbj.2021.05.018","volume":"19","author":"V Namasivayam","year":"2021","unstructured":"Namasivayam V, Silbermann K, Pahnke J, Wiese M, Stefan SM (2021) Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA). Comput Struct Biotechnol J 19:3269\u20133283. https:\/\/doi.org\/10.1016\/j.csbj.2021.05.018","journal-title":"Comput Struct Biotechnol J"},{"issue":"5","key":"775_CR9","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/bioinformatics\/btab832","volume":"38","author":"V Namasivayam","year":"2022","unstructured":"Namasivayam V, Stefan K, Silbermann K, Pahnke J, Wiese M, Stefan SM (2022) Structural feature-driven pattern analysis for multitarget modulator landscapes. Bioinformatics 38(5):1385\u20131392. https:\/\/doi.org\/10.1093\/bioinformatics\/btab832","journal-title":"Bioinformatics"},{"key":"775_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ijbiomac.2022.07.062","volume":"217","author":"V Namasivayam","year":"2022","unstructured":"Namasivayam V, Stefan K, Gorecki L, Korabecny J, Soukup O, Jansson PJ, Pahnke J, Stefan SM (2022) Physicochemistry shapes bioactivity landscape of pan-ABC transporter modulators: anchor point for innovative Alzheimer\u2019s disease therapeutics. Int J Biol Macromol 217:775\u2013791. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.07.062","journal-title":"Int J Biol Macromol"},{"key":"775_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22125","author":"SM Stefan","year":"2023","unstructured":"Stefan SM, Rafehi M (2023) Medicinal polypharmacology \u2013 exploration and exploitation of the polypharmacolome in modern drug development. Drug Dev Res. https:\/\/doi.org\/10.1002\/ddr.22125","journal-title":"Drug Dev Res"},{"key":"775_CR12","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.8363783","author":"SM Stefan","year":"2023","unstructured":"Stefan SM, Pahnke J, Namasivayam V (2023), HD_BPMDS\u2014a curated binary pattern multitarget dataset of Huntington\u2019s disease\u2013targeting agents. zenodo. https:\/\/doi.org\/10.5281\/zenodo.8363783"},{"key":"775_CR13","doi-asserted-by":"crossref","unstructured":"Stefan SM, Pahnke J, Namasivayam V (2023), HD_BPMDS\u2014a curated binary pattern multitarget dataset of Huntington\u2019s disease\u2013targeting agents. panabc.info. http:\/\/www.panabc.info","DOI":"10.1186\/s13321-023-00775-z"},{"key":"775_CR14","doi-asserted-by":"publisher","unstructured":"Stefan SM, Pahnke J, Namasivayam V (2023), HD_BPMDS\u2014a curated binary pattern multitarget dataset of Huntington\u2019s disease\u2013targeting agents. OSF.io. https:\/\/doi.org\/10.17605\/OSF.IO\/EJVWY","DOI":"10.17605\/OSF.IO\/EJVWY"},{"issue":"23","key":"775_CR15","doi-asserted-by":"publisher","first-page":"14763","DOI":"10.3390\/ijms232314763","volume":"23","author":"J Wu","year":"2022","unstructured":"Wu J, Mohle L, Bruning T, Eiriz I, Rafehi M, Stefan K, Stefan SM, Pahnke J (2022) A novel Huntington\u2019s disease assessment platform to support future drug discovery and development. Int J Mol Sci 23(23):14763. https:\/\/doi.org\/10.3390\/ijms232314763","journal-title":"Int J Mol Sci"},{"issue":"24","key":"775_CR16","doi-asserted-by":"publisher","first-page":"15993","DOI":"10.1021\/acs.jmedchem.2c00799","volume":"65","author":"S Ahamad","year":"2022","unstructured":"Ahamad S, Bhat SA (2022) The emerging landscape of small-molecule therapeutics for the treatment of Huntington\u2019s disease. J Med Chem 65(24):15993\u201316032. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00799","journal-title":"J Med Chem"},{"key":"775_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.17879\/freeneuropathology-2021-3528","volume":"2","author":"J Pahnke","year":"2021","unstructured":"Pahnke J, Bascunana P, Brackhan M, Stefan K, Namasivayam V, Koldamova R, Wu J, Mohle L, Stefan SM (2021) Strategies to gain novel Alzheimer\u2019s disease diagnostics and therapeutics using modulators of ABCA transporters. Free Neuropathol. 2:33. https:\/\/doi.org\/10.17879\/freeneuropathology-2021-3528","journal-title":"Free Neuropathol."},{"issue":"6","key":"775_CR18","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/med.21573","volume":"39","author":"M Wiese","year":"2019","unstructured":"Wiese M, Stefan SM (2019) The A-B-C of small-molecule ABC transport protein modulators: from inhibition to activation-a case study of multidrug resistance-associated protein 1 (ABCC1). Med Res Rev 39(6):2031\u20132081. https:\/\/doi.org\/10.1002\/med.21573","journal-title":"Med Res Rev"},{"issue":"1","key":"775_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/med.21510","volume":"39","author":"SM Stefan","year":"2019","unstructured":"Stefan SM, Wiese M (2019) Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: a historic approach and recent advances. Med Res Rev 39(1):176\u2013264. https:\/\/doi.org\/10.1002\/med.21510","journal-title":"Med Res Rev"},{"issue":"7","key":"775_CR20","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.drudis.2022.04.003","volume":"27","author":"W Liu","year":"2022","unstructured":"Liu W, Wang G, Wang Z, Wang G, Huang J, Liu B (2022) Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases. Drug Discov Today 27(7):1994\u20132007. https:\/\/doi.org\/10.1016\/j.drudis.2022.04.003","journal-title":"Drug Discov Today"},{"key":"775_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105642","volume":"120","author":"SJ Devadiga","year":"2022","unstructured":"Devadiga SJ, Bharate SS (2022) Recent developments in the management of Huntington\u2019s disease. Bioorg Chem 120:105642. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105642","journal-title":"Bioorg Chem"},{"issue":"4","key":"775_CR22","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s13311-020-00891-w","volume":"17","author":"D Dash","year":"2020","unstructured":"Dash D, Mestre TA (2020) Therapeutic update on Huntington\u2019s disease: symptomatic treatments and emerging disease-modifying therapies. Neurotherapeutics 17(4):1645\u20131659. https:\/\/doi.org\/10.1007\/s13311-020-00891-w","journal-title":"Neurotherapeutics"},{"issue":"4","key":"775_CR23","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/ajmg.a.38494","volume":"176","author":"AS Dickey","year":"2018","unstructured":"Dickey AS, La Spada AR (2018) Therapy development in Huntington disease: from current strategies to emerging opportunities. Am J Med Genet A 176(4):842\u2013861. https:\/\/doi.org\/10.1002\/ajmg.a.38494","journal-title":"Am J Med Genet A"},{"key":"775_CR24","doi-asserted-by":"publisher","first-page":"CD006456","DOI":"10.1002\/14651858.cd006456.pub2","volume":"3","author":"T Mestre","year":"2009","unstructured":"Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C (2009) Therapeutic interventions for symptomatic treatment in Huntington\u2019s disease. Cochrane Database Syst Rev 3:CD006456. https:\/\/doi.org\/10.1002\/14651858.cd006456.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"775_CR25","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41598-020-57691-7","volume":"10","author":"NL Patel-Murray","year":"2020","unstructured":"Patel-Murray NL, Adam M, Huynh N, Wassie BT, Milani P, Fraenkel E (2020) A multi-omics interpretable machine learning model reveals modes of action of small molecules. Sci Rep 10(1):954. https:\/\/doi.org\/10.1038\/s41598-020-57691-7","journal-title":"Sci Rep"},{"issue":"1","key":"775_CR26","doi-asserted-by":"publisher","first-page":"17803","DOI":"10.1038\/s41598-017-17378-y","volume":"7","author":"F Pei","year":"2017","unstructured":"Pei F, Li H, Henderson MJ, Titus SA, Jadhav A, Simeonov A, Cobanoglu MC, Mousavi SH, Shun T, McDermott L, Iyer P, Fioravanti M, Carlisle D, Friedlander RM, Bahar I, Taylor DL, Lezon TR, Stern AM, Schurdak ME (2017) Connecting neuronal cell protective pathways and drug combinations in a Huntington\u2019s disease model through the application of quantitative systems pharmacology. Sci Rep 7(1):17803. https:\/\/doi.org\/10.1038\/s41598-017-17378-y","journal-title":"Sci Rep"},{"issue":"1","key":"775_CR27","doi-asserted-by":"publisher","first-page":"19642","DOI":"10.1038\/s41598-022-21900-2","volume":"12","author":"SM Galyan","year":"2022","unstructured":"Galyan SM, Ewald CY, Jalencas X, Masrani S, Meral S, Mestres J (2022) Fragment-based virtual screening identifies a first-in-class preclinical drug candidate for Huntington\u2019s disease. Sci Rep 12(1):19642. https:\/\/doi.org\/10.1038\/s41598-022-21900-2","journal-title":"Sci Rep"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-023-00775-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-023-00775-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-023-00775-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T23:06:43Z","timestamp":1703545603000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-023-00775-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1186\/s13321-023-00775-z","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]},"assertion":[{"value":"21 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}